Munich Re's €24 Dividend and Portfolio Overhaul: A Reinsurer in Full Reinvention

Munich Re shareholders vote on €2.25bn buyback and €24 dividend amid a radical shift into tech stocks and new risk frontiers like defence and pandemics.

Shareholders in Munich Re are heading into a pivotal week, with the company’s annual general meeting on Wednesday set to approve a €2.25bn share buyback programme and a sharply higher dividend of €24.00 per share. But beneath the headline capital returns, the reinsurer is quietly executing a radical repositioning of its investment portfolio and expanding into new risk frontiers.

The stock closed Friday at €551.80, down 2.3% on the week and nursing a 12-month decline that stands in stark contrast to the group’s robust operational performance. Technical indicators suggest the shares are oversold in the near term, with a relative strength index reading of 26.4, while the price trades just below both its 50-day and 200-day moving averages.

A Record Payout and a New Auditor

The AGM at Munich’s ICM convention centre will put capital allocation centre stage. The board is proposing a dividend of €24.00 per share for the 2025 financial year, a significant increase on the prior year’s payout. The ex-dividend date falls on Thursday 30 April, with payment expected on 5 May.

Alongside the dividend, management is seeking shareholder approval for a new share buyback programme worth up to €2.25bn, with a term running until the next regular AGM in April 2027. The proposals form part of the “Ambition 2030” strategy unveiled in December, which targets a return on equity above 18% by the end of the decade and average annual earnings per share growth of more than 8%.

For the current financial year 2026, Munich Re is guiding for net profit of €6.3bn on insurance revenue of around €64bn. In a separate governance move, KPMG is set to replace the existing auditor, pending shareholder approval.

Radical Surgery on the US Portfolio

While the AGM grabs headlines, a deeper transformation is underway in Munich Re’s investment book. Fourth-quarter 2025 filings reveal a dramatic shake-up of the group’s US equity holdings, with defensive names jettisoned in favour of technology exposure.

The scale of the repositioning is striking. Munich Re slashed its stake in biotech giant Amgen by 93.8%, cut its holding in financial services firm Ameriprise Financial by 90.6%, and sold more than 86% of its position in discount retailer Dollar General. In a mirror-image move, the group increased its stake in software company Adobe by more than 1,300%, taking the position to a value of over $3m.

The portfolio overhaul signals a clear shift in risk appetite, with the reinsurer rotating out of traditional defensive sectors and into higher-growth technology names.

New Frontiers: Defence and Pandemics

Beyond the balance sheet, Munich Re is also expanding its strategic footprint. The group’s asset management arm, MEAG, has signed on as an early anchor investor in a European defence investment platform launched by Warburg Pincus. The private equity vehicle will focus on security and resilience investments, a sector that chief investment officer Nicholas Gartside said is becoming increasingly critical for European stability.

Meanwhile, Munich Re Specialty has launched a new pandemic risk insurance consortium at Lloyd’s in London. The coverage will only trigger when the World Health Organisation declares a pandemic, a global state of emergency is in place, and authorities impose restrictions. The initiative draws on the expertise of the group’s in-house epidemic risk unit, aiming to provide structured cover for large-scale business interruption in future health crises.

What Lies Ahead

The AGM marks the beginning of a busy period for the Munich Re share. The stock enters the new trading week against a volatile macro backdrop, with elevated oil prices driven by geopolitical tensions in the Middle East, the start of US tech earnings season, and a Federal Reserve interest rate decision that could set the tone for broader markets.

Investors will get their first look at 2026 operational performance on 12 May, when the group publishes its first-quarter results. Until then, the focus remains on Wednesday’s shareholder vote and the strategic signals it sends about the direction of one of Europe’s largest reinsurers.